Prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: A systematic review and meta-analysis

Figure 1 The flow diagram of the study inclusion process.

Figure 2 Forest plot about postoperative International Prostate Symptom Score changes at postoperative 3 mo, 6 mo, 12 mo and 24 mo between the prostate artery embolization group and the transurethral resection of the prostate group.

Figure 3 Forest plot about quality of life score changes at postoperative 3 mo, 6 mo, 12 mo and 24 mo between the prostate artery embolization group and the transurethral resection of the prostate group.

Figure 4 Forest plot about peak urine flow rate changes at postoperative 3 mo, 6 mo, 12 mo and 24 mo between the prostate artery embolization group and the transurethral resection of the prostate group.

Figure 5 Forest plot about postvoid residual volume changes at postoperative 3 mo, 6 mo, 12 mo and 24 mo between the prostate artery embolization group and the transurethral resection of the prostate group.

Figure 6 Forest plot about prostate volume changes at postoperative 3 mo, 6 mo, 12 mo and 24 mo between the prostate artery embolization group and the transurethral resection of the prostate group.

Figure 7 Forest plot about prostate-specific antigen changes at postoperative 3 mo, 6 mo, 12 mo and 24 mo between the prostate artery embolization group and the transurethral resection of the prostate group.

Figure 8 Forest plot about postoperative changes in sexual function between the prostate artery embolization group and the transurethral resection of the prostate group. A: changes in International Index of Erectile Function score; B: changes in erectile dysfunction; C: changes in retrograde ejaculation

Figure 9 Forest plot about procedure time and the hospital stay between the prostate artery embolization group and the transurethral resection of the prostate group. A: Procedure time; B: The hospital stay.